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Abstract: 27 
Background: Although the magnificent improvement in Fontan operation results in 28 
the last two decades, there are still some concerns regarding the unfavourable early 29 
outcomes that may follow Fontan completion. 30 
Methods: From 2003 to 2016, 79 Patients underwent Fontan operation at IRCCS 31 
Policlinico San Donato. Unfavourable early outcome was defined by the presence of 32 
one or more of these occurrences: prolonged hospital stay > 25 days, Prolonged 33 
pleural effusion > 14 days and Prolonged inotropic support > 72 hours. Univariable 34 
and multivariable analyses were performed to detect the risk factors associated with 35 
early unfavourable outcome after Fontan completion. 36 
Results: Prolonged hospital stay > 25 days was found in 24.05% of patients and its 37 
associated significant risk factors were low preoperative O2 saturation (p 0.007), 38 
Fontan fenestration (p 0.009) and plasma transfusion (p 0.030). Prolonged pleural 39 
effusion > 14 days was found in 24.05% and no significant risk factors were detected. 40 
Prolonged inotropic support > 72 hours was found in 35.44% and significant risk 41 
factors were prolonged cardiopulmonary bypass time (P 0.003), fenestration (P 42 
0.023), plasma transfusion (P 0.028) and non staged Fontan (P 0.039). In 43 
multivariable analysis of combined unfavourable outcome, significant risk factors 44 
were fenestration (P 0.030) with some trends towards low preoperative O2 saturation 45 
(P 0.056). 46 
Conclusion: Unfavourable early outcome can occur following Fontan completion 47 
with associated prolonged hospital stay. Risk factors include low preoperative O2 48 
saturation, prolonged cardiopulmonary bypass time, Fontan fenestration, Plasma 49 
transfusion and non staged Fontan. 50 
 51 
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(1) Introduction 52 
Since the introduction of Fontan operation by Fontan and Baudet [1] in 1971, several 53 
modifications have been applied to it with the same basic concept of directing 54 
systemic venous return directly to the pulmonary arteries bypassing the right side of 55 
the heart.  56 
The extracardiac conduit using Goretex tube with inferior cavo-pulmonary connection 57 
is considered the most routinely used technique for Fontan completion in these days 58 
since published by Marcelletti et al. in 1990. [2] 59 
Thanks to the many adjustments applied to this procedure and marked improvement 60 
in the postoperative care through the last two decades, surgical results have been 61 
much improved and the incidence of mortality and early failure have markedly 62 
declined recently [3, 4, 5] 63 
However, unfavourable postoperative morbidities are still present and several patients 64 
need prolonged length of stay after the operation. In this study we investigate risk 65 
factors associated with unfavourable early outcome after Fontan completion. 66 
 67 
(2) Patients and Methods: 68 
We included all patients who had Fontan procedure at IRCCS Policlinico San Donato 69 
(Milan, Italy) in 14 years from 2003 to 2016 with the exclusion of conversion of 70 
previous atrio-pulmonary anastomosis and lateral tunnel to extracardiac Fontan. 71 
Retrospective review of patients' charts, preoperative, operative and postoperative 72 
notes was conducted to collect the studied variables. 73 
 In this study prolonged length of stay was defined if more than 75 percentile (> 25 74 
days) and prolonged pleural effusion was defined as per greater than 75 percentile 75 
after surgery (> 14 days). Prolonged inotropic support was defined as major 76 
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catecholamines administration for > 72 hours. The presence of one or more of these 77 
occurrences was defined as combined unfavorable outcome. 78 
 79 
Patients population 80 
A total of 79 patients were included in the study. Demographic data and 81 
univentricular cardiac anomalies are summarized in the table 1 and 2. Previous 82 
modified B-T shunt was done in 33 patients (41.77%) while 31 patients (39.24%) had 83 
previous pulmonary artery banding. 21 patients (26.58%) required previous atrial 84 
septectomy. Previous bidirectional Glenn was performed in 66 patients (83.5%), while 85 
13 patients (16.5%) had bidirectional Glenn anastomosis at the same time of Fontan.  86 
The type of Fontan operation used was extracardiac conduit in 93.7% (n=74) of 87 
patients and the remaining patients had intracardiac tunnel (n=5). Fenestration was 88 
needed only in 10 cases (12.7%).  All cases were operated on cardiopulmonary 89 
bypass. Aortic cross clamp and cardioplegia were used in 35.4% of cases (n=28). 90 
Eleven patients needed AV valve repair (13.9%). Median intensive care unit stay was 91 
3 days (IQR: 2-4 days). Median hospital stay was 18 days (IQR: 13-25 days). There 92 
was no hospital mortality although 2 patients had Fontan take down due to failure and 93 
high pressure in the circuit. Post operative data are shown in table 3. 94 
 95 
Statistical Analysis: 96 
All continuous parameters were given as median and inter quartile range (IQR). 97 
Categorical data were summarized as frequencies and percentages. Univariable 98 
analysis using logistic regression was used to identify risk factors for prolonged 99 
hospital stay, prolonged pleural drainage duration, prolonged inotropic support and 100 
combined unfavourable outcome. The significant variables associated with combined 101 
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unfavourable outcome were used to construct the multivariable logistic regression. P- 102 
value was considered significant when < 0.05. Data analyses were performed with 103 
Stata Statistical Software (Release 12; StataCorp 2011College Station. TX: StataCorp 104 
LP).  105 
 106 
(3) Results 107 
Unfavourable postoperative outcome 108 
The statistical analysis on unfavorable early postoperative course was performed 109 
taking in consideration 28 variables. 110 
1- Prolonged hospital stay, defined as hospital stay more than 25 days after Fontan 111 
completion. 112 
2- Prolonged pleural effusion, defined as longer than 14 days. 113 
3- Prolonged inotropic support, defined as catecholamine administration to maintain 114 
circulation for > 72 hours. 115 
 116 
 A- Prolonged hospital stay: 117 
Prolonged hospital stay > 25 days was found in 19 patients (24.05%). Univariable 118 
analysis for associated risk factors was done and shown in table 4. Significant risk 119 
factors correlated with prolonged hospital stay were low preoperative O2 saturation (p 120 
0.007), Fontan fenestration (p 0.009) and plasma transfusion in postoperative day 0 (p 121 
0.030).  122 
 123 
B- Prolonged pleural effusion: 124 
Prolonged pleural effusion > 14 days was found in 19 patients (24.05%). Univariable 125 
analysis for associated risk factors was done and showed that no significant risk 126 
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factors were detected. Eleven patients (13.9%) required placement of additional chest 127 
tube for re-accumulation of pleural effusion after removal of previous chest tubes.  128 
 129 
C- Prolonged inotropic support: 130 
Prolonged inotropic support > 72 hours was found in 28 patients (35.44%). 131 
Univariable analysis for associated risk factors was done and showed that significant 132 
risk factors were cardiopulmonary bypass time (P-value 0.003), fenestration (P-value 133 
0.023), plasma transfusion in postoperative day 0 (P-value 0.028) and non staged 134 
Fontan with concomitant bidirectional Glenn at the same intervention (P-value 0.039) 135 
as shown in table 5. 136 
 137 
 138 
Combined unfavorable outcome: -D 139 
After studying combined outcome regarding the 3 variables we have selected for 140 
unfavorable outcome, we found that 33 patients (41.77%) lie in this category. 141 
Univariable and multivariable analyses by logistic regression were done for risk 142 
factors associated with unfavorable outcome and significant risk factors are shown in 143 
tables 6 and 7. In univariable analysis, risk factors were fenestration (P-value 0.019), 144 
long cardiopulmonary bypass time (P-value 0.026), low preoperative O2 saturation (P- 145 
value 0.027) and plasma transfusion (P-value 0.036). In multivariable analysis, 146 
cardiopulmonary bypass time (P-value 0.168) and plasma transfusion (P-value 0.081) 147 
lost their significance, while significant risk factors were fenestration (P-value 0.030) 148 
with some trends towards low preoperative O2 saturation (P-value 0.056).  149 
 150 
 151 
(4) Discussion: 152 
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 This study reviews 14 years experience of Fontan operation at IRCCS Policlinico San 153 
Donato (Italy) and evaluates the early outcome and the risk factors for postoperative 154 
unfavourable outcomes. 155 
Regarding prolonged hospital stay after Fontan operation, Sasaki et al. [6] defined 156 
prolonged length of stay as hospital stay greater than 75 percentile after surgery which 157 
was defined greater than or equal to 15 days. Independent risk factors for prolonged 158 
length of stay included high hemoglobin level (odds ratio, 1.29; p = 0.003), high mean 159 
pulmonary artery pressure (odds ratio, 1.14; p = 0.037), low aortic saturation (odds 160 
ratio, 0.92; p = 0.008) and fenestration (odds ratio, 2.4; p = 0.021). Other previous 161 
studies focusing on prolonged hospital stay reported higher PAP, decreasing systemic 162 
oxygen saturation, old age and the diagnosis of HLHS as risk factors. [7, 8, 9] 163 
In our study, prolonged hospital stay was found in 19 patients (24.05%). Significant 164 
risk factors were fenestration (P-value 0.009), low preoperative O2 saturation (P-value 165 
0.007) and plasma transfusion (P-value 0.030). 166 
Our finding that the presence of a fenestration is associated with increased length of 167 
stay and postoperative complications is in contrast to most prior reports, and deserves 168 
mention. In many prior reports, fenestration has been associated with better outcomes 169 
[10, 11], including a decreased risk of death, decreased pleural effusion duration and 170 
less hospital stay. In particular, Lemler et al. [12] performed the prospective 171 
randomized trial to investigate the clinical utility of fenestration in patients with 172 
standard preoperative risk profiles for 49 consecutive Fontan operations. They 173 
concluded that baffle fenestration improves short term outcome in standard-risk 174 
patients by decreasing pleural drainage, hospital stay, and need for additional 175 
postoperative procedures. In our series, where fenestration was used in a particular 176 
subgroup of high risk patients, the association of prolonged length of stay and more 177 
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complications is consistent with their high risk nature, rather than the presence of the 178 
fenestration per se. The same happened with plasma transfusion which was usually 179 
associated with low cardiac output state early in ICU and those patients represent 180 
more complex cases who needed more time for optimization of the cardiac output. It's 181 
recommended to perform Fontan completion early before deterioration of O2 182 
saturation because in our series it is found that low preoperative O2 saturation is a risk 183 
factor for prolonged hospitalization. 184 
Regarding pleural effusion, median drainage days was 8 days (IQR: 6-13 days). 185 
Pleural effusions after the Fontan operation contribute significantly to morbidity and 186 
prolonged hospitalization. Prolonged pleural effusion > 14 days was found in 19 187 
patients (24.05%) and no significant associated risk factors were detected. Gupta et al. 188 
[13] studied risk factors for persistent pleural effusion after extracardiac Fontan and 189 
stated that 37% had pleural drainage lasting > 14 days and significant risk factors 190 
were lower preoperative oxygen saturation (P-value,  0.011) and the presence of 191 
postoperative infections (P-value, 0.003). Fu et al. [14] reported that 38.9% of patients 192 
had pleural effusion for more than 15 days and multivariate analysis results showed 193 
that non-fenestration, low preoperative oxygen saturation, and postoperative 194 
infections were independent risk factors or prolonged pleural effusion. Fenestration of 195 
the Fontan baffle has been reported to significantly reduce the duration of pleural 196 
effusions in several reports. [11, 12] 197 
In our experience we do not routinely perform fenestration of the extracardiac baffle. 198 
This procedure is reserved for patients with high risk hemodynamics and increased 199 
pulmonary pressure detected by increased CVP. In our study, the presence of 200 
fenestration was not found to significantly affect persistent pleural effusions. 201 
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In the study published by Ovroutski et al [15], prolonged inotropic support > 72 hours 202 
was found in 21,4 % of patients following Fontan completion demonstrating that 203 
heterotaxia, the presence of a systemic right ventricle, low preoperative arterial 204 
oxygen saturation and the use of cardioplegia were significant risk factors (P-value < 205 
0.05). 206 
In our series, prolonged inotropic support > 48 hours was found in 28 patients 207 
(35.44%). Significant risk factors were cardiopulmonary bypass time (P-value 0.003), 208 
fenestration (P-value 0.023), plasma transfusion (P-value 0.028) and non staged 209 
Fontan with concomitant bidirectional Glenn at the same intervention (P-value 0.039). 210 
Although both long cardiopulmonary bypass time and non staged Fontan are risk 211 
factors similar to those reported in the Literature, fenestration as a risk factor seems to 212 
be peculiar of our experience. The association of fenestration with prolonged 213 
inotropic support, prolonged hospital stay and combined unfavorable outcome is 214 
explained by patient selection and the indication of this procedure only in high risk 215 
cases. 216 
  217 
Limitations: 218 
The main limitation of the study is its relatively small number of patients, its 219 
retrospective nature and being a single center study. To detect more risk factors of 220 
unfavourable early outcome following Fontan completion and to ameliorate the 221 
postoperative course, a multicenter study with standard selection criteria may be 222 
needed in the future to refine statistical analysis outcomes and help in avoiding or 223 
reducing the risk of unfavourable early outcome after Fontan completion. 224 
 225 
 226 
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(5) Conclusion: 227 
Unfavourable early outcome with prolonged hospital stay remains a frequent issue 228 
following Fontan completion. Risk factors include low preoperative O2 saturation, 229 
prolonged cardiopulmonary bypass time, Fontan fenestration, Plasma transfusion and 230 
non staged Fontan.   231 
Fontan staging, minimizing cardiopulmonary bypass time duration, optimizing low 232 
cardiac output treatment and early Fontan completion before deterioration of arterial 233 
O2 saturation must be performed in order to improve the results in terms of 234 
complicated course with prolonged length of stay. 235 
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Tables: 337 
 338 
Table 1: Demographic and preoperative data: 339 
Variable Mean SD Median IQR Min. Max. 
Age 9.66 6.29 7.3 5.6 -  11.5 2.88 33.9 
Weight 28.47 16.03 21 17 -  37 12 84 
Height 126.32 23.02 125 108 - 143 91 183 
BSA 0.98 0.36 0.88 0.71 – 1.23 0.56 2.07 
E F % 70.2 6.57 70 70 – 75 50 80 
PAP mean 12.4 3.56 13 10 – 15 4 20 
Creatinin preop 0.51 0.17 0.5 0.4 – 0.6 0.2 1.13 
Ht. preop. 49.32 6.03 48.6 45 - 53.3 38 74 
Bilirubin preop. 0.88 0.56 0.71 0.5 – 1.05 0.21 3.4 
Glenn-Fontan interval yrs 6.45 4.72 5 3.5 – 8 1 27 
BSA= Body surface area, EF%= Ejection fraction, PAP mean= mean pulmonary artery pressure, 340 
Ht=hematocrit 341 
 342 
 343 
 344 
 345 
 346 
 347 
 348 
 349 
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 350 
 351 
 352 
Table 2: Diagnosis 353 
Diagnosis N Percentage(%) 
Tricuspid atresia 20 25.32% 
DORV 15 18.99% 
DILV 10 12.66% 
HLHS 8 10.13% 
AVSD 5 6.33% 
Isomerism 4 5.06% 
Pulmonary atresia 3 3.80% 
TGA 6 7.59% 
Univentricular heart 5 6.33% 
CC-TGA 3 3.80% 
Total 79 100% 
Table (1): List of diagnosis 354 
DORV= double outlet right ventricle , DILV= double inlet left ventricle , HLHS= hypoplastic left heart 355 
syndrome , AVSD= atrio ventricular septal defect , TGA= transposition of great arteries , CC-TGA= 356 
congenitally corrected transposition of great arteries.  357 
 358 
 359 
 360 
 361 
 362 
 363 
 364 
 365 
 366 
 367 
 368 
 369 
 370 
 371 
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 372 
Table 3: Post operative features:  373 
Variable Mean ±SD Median IQR Min Max 
Heart rate 115.5 18.05 118 103 – 130 70 148 
MAP 68.6 15.20 69 56 – 79 34 103 
CVP 15.2 3.1 15 13 – 18 7 23 
Hct 37.4 6.55 37 33 – 41 25 71 
MV (hrs) 23.5 69.6 11 7 – 16 1 560 
Drainage Days 10.66 6.04 8 6 – 13 3 27 
ICU Stay 3.7 3.98 3 2 – 4 1 30 
Hospital Stay 21.11 11.55 18 13 – 25 8 64 
   374 
 MAP= mean arterial pressure, CVP= central venous pressure, Hct= hematocrit%, MV= mechanical 375 
ventilation .   376 
 377 
 378 
 379 
 380 
 381 
 382 
 383 
 384 
 385 
 386 
 387 
 388 
  389 
  390 
  391 
  392 
 393 
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Table 4: Univariable analysis of risk factors of prolonged hospital stay  394 
95% Confidence interval P-value Z Standard error Odds Ratio Variables 
0.87 – 1.06 0.424 - 0.80 0.05 0.96 Age 
0.97 – 1.04 0.704 0.38 0.016 1.006 Weight 
0.978 – 1.023 0.991 0.01 0.012 1 Height 
0.29 – 5.14 0.780 0.28 0.897 1.23 BSA 
0.87 – 1.167 0.909 0.11 0.75 1.01 Pap mean 
0.83 – 0.97 0.007 - 2.70 0.04 0.896 Preop. O2 saturation 
0.014 – 9.58 0.543 - 0.61 0.605 0.36 Creatinine Preop 
0.912 – 1.08 0.901 - 0.12 0.044 0.995 Hct 
0.179 – 1.78 0.33 - 0.98 0.33 0.56 Bilirubin 
0.99 – 1.42 0.059 1.89 0.108 1.187 Diagnosis 
0.26 – 2.21 0.618 - 0.50 0.41 0.76  mB-T shunt 
0.55 – 4.41 0.407 0.83 0.83 1.55 PA banding 
0.38 – 9.49 0.430 0.79 1.56 1.91 BD Glenn 
0.64 – 1.43 0.840 - 0.20 0.197 0.96 Avv regurge 
0.39 – 3.52 0.784 0.27 0.66 1.16 Antegrade flow 
0.103 – 10.79 0.964 0.05 1.25 1.06 Preop. arrhythmia 
0.134 – 12.26 0.827 0.22 1.48 1.29 Extracardiac 
1.59 – 26.25 0.009 2.61 4.62 6.46 Fenestration 
0.99 – 1.02 0.438 0.78 0.006 1.005 Bypass time 
0.84 – 1.06 0.345 - 0.94 0.056 0.95 Low Hct 
0.79 – 1.34 0.852 0.19 0.14 1.03 Low temp. 
0.97 – 1.04 0.959 0.05 0.017 1 MAP 
0.86 – 1.199 0.873 0.16 0.87 1.014 CVP 
0.93 – 1.09 0.807 0.24 0.039 1 Hct 
0.74 – 48.84 0.094 1.67 6.42 6 Transfusion 
0.79 – 9.04 0.112 1.59 1.66 2.68 Blood 
1.15 – 16.56 0.030 2.16 2.97 4.36 Plasma 
0.042 – 3.09 0.352 - 0.93 0.396 0.36 Platelets 
 395 
  396 
BSA = body surface area, pap= pulmonary artery pressure, MAP= mean arterial pressure, CVP= central 397 
venous pressure.  398 
  399 
  400 
  401 
  402 
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 403 
Table 5: Significant risk factors associated with prolonged inotropic support:  404 
95 % Confidence 
interval 
P-value Z Standard error Odds Ratio Variables 
0.08 – 0.93 0.039 - 2.07 0.17 0.27 BD Glenn 
1.26 – 22.66 0.023 2.27 3.94 5.33 Fenestration 
1.007 – 1.04 0.003 3 0.007 1.02 Bypass time 
1.13 – 9.38 0.028 2.19 1.76 3.26 Plasma 
 405 
 406 
 407 
 408 
 409 
 410 
 411 
 412 
 413 
 414 
 415 
 416 
 417 
 418 
 419 
 420 
 421 
 422 
 423 
 424 
 425 
 426 
 427 
 428 
 429 
 430 
 431 
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Table 6: Significant risk factors associated with combined unfavorable outcome 432 
after univariable analysis:  433 
 434 
95 % Confidence 
interval 
P-value Z 
Standard 
error 
Odds 
Ratio 
Variables 
1.39 – 35.77 0.019 2.35 5.84 7.04 Fenestration 
1.002 – 1.03 0.026 2.23 0.006 1.01 Bypass time 
1.07 – 7.66 0.036 2.10 1.44 2.86 Plasma 
0.85 – 0.99 0.027 - 2.21 0.35 0.92 O2 sat. % 
  435 
  436 
  437 
 438 
 439 
 440 
 441 
 442 
 443 
 444 
 445 
 446 
 447 
 448 
 449 
 450 
 451 
 452 
 453 
 454 
 455 
 456 
 457 
 458 
 459 
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Table 7: Multivariable analysis for significant risk factors associated with 460 
unfavorable outcome:  461 
 462 
95 % Confidence 
interval 
P-value Z 
Standard 
error 
Odds 
Ratio 
Variables 
1.29 – 41.95 0.025 2.14 6.53 7.35 fenestration 
0.996 – 1.02 0.168 1.38 0.007 1.01 Bypass time 
0.89 – 8.06 0.081 1.74 1.50 2.67 Plasma 
0.86 – 1.002 0.056 - 1.91 0.04 0.93 O2 sat. % 
 463 
 464 
